C4 Therapeutics vs Latus Bio
C4 Therapeutics vs Latus Bio, compared side by side on 17 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: C4 Therapeutics is on 49/100 and Latus Bio on 54/100.
Where each one leads
C4 Therapeutics
- domain rating: 41/100 against 25/100
- funding raised: $371M against $151M
Latus Bio
- our overall score: 54/100 against 49/100
- agent readiness: 36/100 against 21/100
At a glance
| Measure | C4 Therapeutics | Latus Bio |
|---|---|---|
| What it is | Biopharmaceutical company developing novel cancer therapies using targeted protein degradation. | Engineering scalable gene therapies for broader patient populations. |
| Category | Biotech, Drug Discovery, Oncology, Clinical Trials | Biotechnology, Gene Therapy, Healthcare, Biotech |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Platform |
| Founded | 2016 | 2022 |
| Headquarters | Boston, United States | Boston, USA |
| Status | Active | Active |
Size, funding and growth
| Measure | C4 Therapeutics | Latus Bio |
|---|---|---|
| Employees | Not published | 27 |
| Total funding | $371M | $151M |
| Latest round | Series D | Series A (Extension) |
| LinkedIn followers | Not published | 3,459 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | C4 Therapeutics | Latus Bio |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 49/100 | 54/100 |
| Traction | 40/100 | 54/100 |
| Team | 20/100 | 70/100 |
| Search visibility | 3/100 | 35/100 |
| Quality | 68/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (21/100) | F (36/100) |
| Domain ratingLink authority, 0-100 | 41/100 | 25/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | C4 Therapeutics | Latus Bio |
|---|---|---|
| Hosting | Google Cloud | Not detected |
| CDN | Not detected | Cloudflare |
| CMS | WordPress | Webflow |
| Frameworks | Not detected | Jquery |
| Analytics | Google Analytics 4, Google Tag Manager | Not detected |
C4 Therapeutics vs Latus Bio: common questions
Which is better, C4 Therapeutics or Latus Bio?
On our 0-100 score Latus Bio rates higher (54/100 against 49/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 17 data points above: read the rows that match what you are buying for.
How do C4 Therapeutics and Latus Bio compare on the numbers?
C4 Therapeutics leads on domain rating (41/100 against 25/100), funding raised ($371M against $151M). Latus Bio leads on our overall score (54/100 against 49/100), agent readiness (36/100 against 21/100).
Read the full C4 Therapeutics review and pricing or the Latus Bio review and pricing. You can also browse other C4 Therapeutics alternatives we track.